Skip to main content
Log in

Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To investigate whether among patients with a negative temporal artery biopsy (TAB) there are clinical features that may differentiate between patients with an eventual diagnosis of giant cell arteritis (GCA) and those without arteritis, and to assess the eventual diagnoses of patients without arteritis. Retrospective analysis of patients with a negative TAB performed between 1/1/2000 and 31/12/2015. Information collected included baseline clinical and laboratory data. Patients’ final diagnoses were obtained from medical records. Patients eventually diagnosed with GCA were compared with those without arteritis, and predictive features for GCA diagnosis were assessed. A total of 154 patients with a negative TAB were included in the study. Among them, 31 (20%) were eventually diagnosed with GCA. The leading alternative diagnoses of patients without arteritis were self-limited disease (23%), isolated polymyalgia rheumatica (PMR) (18%), and neurological conditions (17%). In the multivariate analysis, predictors for diagnosis of GCA among patients with a negative TAB included PMR (OR = 2.86, 95% CI 1.06–7.69), platelet count (OR = 1.28, 95% CI 1.07–1.53), and ACR score > 2 (OR = 13.4, 95% CI 4.27–42.03). Among patients with a negative TAB, the best predictors for diagnosis of GCA are fulfillment of the ACR criteria, a clinical diagnosis of PMR, and high platelet levels. These features may aid in the diagnostic work-up of patients with a negative TAB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61:1454–1461

    Article  PubMed  Google Scholar 

  2. Nesher G (2014) The diagnosis and classification of giant cell arteritis. J Autoimmun 48–49:73–75

    Article  PubMed  CAS  Google Scholar 

  3. Muratore F, Pazzola G, Pipitone N, Boiardi L, Salvarani C (2014) Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica. Clin Exp Rheumatol 32(3 Suppl 82):S106–S111

    PubMed  Google Scholar 

  4. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine 84:269–276

    Article  PubMed  Google Scholar 

  5. Jennette JC, Falk RJ (2007) The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 25(1 Suppl 44):S52–S56

    PubMed  CAS  Google Scholar 

  6. Gonzalez-Gay MA (2005) The diagnosis and management of patients with giant cell arteritis. J Rheumatol 32:1186–1188

    PubMed  Google Scholar 

  7. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34:351–356

    Article  PubMed  CAS  Google Scholar 

  8. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249–256

    Article  PubMed  CAS  Google Scholar 

  9. Duhaut P, Pinede L, Bornet H, Demolombe-Rague S, Dumontet C, Ninet J, Loire R, Pasquier J (1999) Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe de Recherche sur l’Arterite a Cellules Geantes. Ann Rheum Dis 58:335–341

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Grossman C, Barshack I, Bornstein G, Ben-Zvi I (2015) Is temporal artery biopsy essential in all cases of suspected giant cell arteritis? Clin Exp Rheumatol 33(2 Suppl 89):S-84–S-89

    Google Scholar 

  11. Narvaez J, Bernad B, Roig-Vilaseca D, Garcia-Gomez C, Gomez-Vaquero C, Juanola X et al (2007) Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 37:13–19

    Article  PubMed  CAS  Google Scholar 

  12. Cavazza A, Muratore F, Boiardi L, Restuccia G, Pipitone N, Pazzola G, Tagliavini E, Ragazzi M, Rossi G, Salvarani C (2014) Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 38:1360–1370

    Article  PubMed  Google Scholar 

  13. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42:311–317

    Article  PubMed  CAS  Google Scholar 

  14. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128

    Article  PubMed  CAS  Google Scholar 

  15. Muratore F, Cavazza A, Boiardi L, Lo Gullo A, Pipitone N, Germano G et al (2016) Histopathologic findings of patients with biopsy-negative giant cell arteritis compared to those without arteritis: a population-based study. Arthrit Care Res 68:865–870

    Article  CAS  Google Scholar 

  16. Breuer GS, Nesher R, Nesher G (2008) Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol 26:1103–1106

    PubMed  CAS  Google Scholar 

  17. Hedges TR 3rd, Gieger GL, Albert DM (1983) The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 101:1251–1254

    Article  PubMed  Google Scholar 

  18. Roth AM, Milsow L, Keltner JL (1984) The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol 102:901–903

    Article  PubMed  CAS  Google Scholar 

  19. Chmelewski WL, McKnight KM, Agudelo CA, Wise CM (1992) Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Archives Intern Med 152:1690–1695

    Article  CAS  Google Scholar 

  20. Jobard S, Magnant J, Blasco H, Ferreira-Maldent N, Griffoul I, Diot E, Maillot F (2017) Quality of life of patients treated for giant cell arteritis: a case-control study. Clin Rheumatol 36:2055–2062

    Article  PubMed  Google Scholar 

  21. Grossman C, Barshack I, Koren-Morag N, Ben-Zvi I, Bornstein G (2016) Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clin Rheumatol 35:1817–1822

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chagai Grossman.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bornstein, G., Barshack, I., Koren-Morag, N. et al. Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis. Clin Rheumatol 37, 2819–2824 (2018). https://doi.org/10.1007/s10067-018-4068-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4068-4

Keywords

Navigation